urbantravels
disjecta membra
- Messages
- 1,333
- Location
- Los Angeles, CA
Doesn't seem to fit the first requirement though:
"1. The study presents the results of primary scientific research."
Or a systematic review. But that definition appears to apply to a review of multiple papers in an area, not a critique of one paper:
Systematic reviews are considered for publication in PLoS ONE but are limited to areas where appropriate standards for conduct and reporting apply and where the methods ensure the utmost rigor in the comprehensive and unbiased sampling of existing literature. A systematic review differs substantially from a narrative-based review or synthesis article and has its roots in the medical sciences (but is beginning to be applied to other disciplines such as environmental sciences). As defined by the Cochrane Centre, it is a review of a clearly formulated question that uses systematic and explicit methods to identify, select, and critically appraise relevant research, and to collect and analyze data from the studies that are included in the review. Statistical methods (meta-analysis) may or may not be used to analyze and summarize the results of the included studies. Please also see our reporting guidelines for such articles.
The other type of thing they publish:
Commissioned reviews, synthesis and commentary articles are considered but only where they form part of an agreed collection.
seems to be editorially driven - but that doesn't mean someone couldn't propose that they do such a collection on the subject of ME/CFS research.
All easy for me to say - all I ever do is sit around and tweet and blog once in a great while - but I do think that multiple avenues of publication should be considered, and PLoS One has the stated editorial goals of providing open access in an accelerated matter, and letting the "marketplace" of ideas decide which articles and papers are significant. I'd bet they're pretty happy with the response that the Fluge/Mella paper has generated.